Last reviewed · How we verify
Talazoparib plus Irinotecan
Talazoparib plus Irinotecan is a Small molecule drug developed by QuantumLeap Healthcare Collaborative. It is currently in Phase 2 development.
At a glance
| Generic name | Talazoparib plus Irinotecan |
|---|---|
| Sponsor | QuantumLeap Healthcare Collaborative |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (PHASE2)
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma (PHASE1, PHASE2)
- PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors (PHASE1)
- Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors (PHASE1, PHASE2)
- Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Talazoparib plus Irinotecan CI brief — competitive landscape report
- Talazoparib plus Irinotecan updates RSS · CI watch RSS
- QuantumLeap Healthcare Collaborative portfolio CI
Frequently asked questions about Talazoparib plus Irinotecan
What is Talazoparib plus Irinotecan?
Talazoparib plus Irinotecan is a Small molecule drug developed by QuantumLeap Healthcare Collaborative.
Who makes Talazoparib plus Irinotecan?
Talazoparib plus Irinotecan is developed by QuantumLeap Healthcare Collaborative (see full QuantumLeap Healthcare Collaborative pipeline at /company/quantumleap-healthcare-collaborative).
What development phase is Talazoparib plus Irinotecan in?
Talazoparib plus Irinotecan is in Phase 2.